Phagenyx® Registry Study
Phagenyx® Registry Study: Evaluating Swallowing Therapy Outcomes and Recovery in the U.S.
Phagenesis Ltd.
600 participants
Sep 15, 2025
OBSERVATIONAL
Conditions
Summary
A retrospective, open-label, matched-control registry study designed to characterize the effectiveness of Pharyngeal Electrical Stimulation (PES) to improve swallowing in patients with severe dysphagia post stroke when delivered using the Phagenyx® System in real-world clinical settings in hospitals in the United States of America (US).
Eligibility
Inclusion Criteria3
- Phagenyx® System Group Patients: Patients underwent treatment with the Phagenyx® System for a minimum of 3 treatments.
- Control Group Patients: Patient requires a nasogastric feeding tube for severe dysphagia and required dysphagia treatment.
- Willing and able to provide appropriate informed consent (if required).
Exclusion Criteria4
- Primary endpoint outcome data not collected or not available.
- In the investigator or sponsor's opinion the patient is not considered suitable.
- Participation in another interventional study (medicinal or device) that could influence the outcomes of PES.
- Treatment of dysphagia with other forms of electrical stimulation.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients who have undergone Pharyngeal Electrical Stimulation (PES) treatment for severe dysphagia using the Phagenyx® System
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06866418